Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018
| Authors | |
|---|---|
| Year of publication | 2018 |
| Type | Conference abstract |
| Citation |